Browse the detailed record of transactions filed by HENWOOD GERALDINE, Chief Executive Officer. Director active across 1 companies, notably Baudax Bio, Inc.. Aggregated, 9 filings have been published. Total volume traded: €16k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
HENWOOD GERALDINE serves as President and CEO at Baudax Bio, Inc. She is responsible for the strategic direction of the company and the management of its daily operations. Under her leadership, Baudax Bio is committed to developing innovative treatments for patients. HENWOOD GERALDINE plays a crucial role in defining the company's vision and establishing strong relationships with investors and partners.